Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51

1.

An Evaluation of Psoriasis Patient Perceptions and Understanding of Biosimilars: A Canadian Survey Comparing Biologic and Nonbiologic Users.

Ighani A, Wang JY, Manolson MF.

J Cutan Med Surg. 2018 May/Jun;22(3):365-367. doi: 10.1177/1203475417746337. Epub 2018 Apr 2. No abstract available.

PMID:
29608867
2.

Molecular mechanisms of cutis laxa- and distal renal tubular acidosis-causing mutations in V-ATPase a subunits, ATP6V0A2 and ATP6V0A4.

Esmail S, Kartner N, Yao Y, Kim JW, Reithmeier RAF, Manolson MF.

J Biol Chem. 2018 Feb 23;293(8):2787-2800. doi: 10.1074/jbc.M117.818872. Epub 2018 Jan 8.

PMID:
29311258
3.

N-linked glycosylation of a subunit isoforms is critical for vertebrate vacuolar H+ -ATPase (V-ATPase) biosynthesis.

Esmail S, Kartner N, Yao Y, Kim JW, Reithmeier RAF, Manolson MF.

J Cell Biochem. 2018 Jan;119(1):861-875. doi: 10.1002/jcb.26250. Epub 2017 Aug 4.

PMID:
28661051
4.

Activity-independent targeting of mTOR to lysosomes in primary osteoclasts.

Wang A, Carraro-Lacroix LR, Owen C, Gao B, Corey PN, Tyrrell P, Brumell JH, Voronov I.

Sci Rep. 2017 Jun 7;7(1):3005. doi: 10.1038/s41598-017-03494-2.

5.

V-ATPases Containing a3 Subunit Play a Direct Role in Enamel Development in Mice.

Johnson L, Ganss B, Wang A, Zirngibl RA, Johnson DE, Owen C, Bradley G, Voronov I.

J Cell Biochem. 2017 Oct;118(10):3328-3340. doi: 10.1002/jcb.25986. Epub 2017 May 3.

PMID:
28295540
6.

Controlled bone formation using ultrasound-triggered release of BMP-2 from liposomes.

Crasto GJ, Kartner N, Reznik N, Spatafora MV, Chen H, Williams R, Burns PN, Clokie C, Manolson MF, Peel SA.

J Control Release. 2016 Dec 10;243:99-108. doi: 10.1016/j.jconrel.2016.09.032. Epub 2016 Sep 28.

PMID:
27693545
7.

N-Linked Glycosylation Is Required for Vacuolar H+ -ATPase (V-ATPase) a4 Subunit Stability, Assembly, and Cell Surface Expression.

Esmail S, Yao Y, Kartner N, Li J, Reithmeier RA, Manolson MF.

J Cell Biochem. 2016 Dec;117(12):2757-2768. doi: 10.1002/jcb.25574. Epub 2016 Sep 7.

PMID:
27127844
8.

Editorial: Flt3 ligand-friend or foe?

Voronov I, Manolson MF.

J Leukoc Biol. 2016 Mar;99(3):401-3. doi: 10.1189/jlb.3CE0915-445RR. No abstract available.

PMID:
26932387
9.

DEL1 - a new player in periodontal disease?

Voronov I.

Oral Dis. 2016 Apr;22(3):169-70. doi: 10.1111/odi.12440. Epub 2016 Feb 3. No abstract available.

PMID:
26781041
10.

Lysosomal pH Plays a Key Role in Regulation of mTOR Activity in Osteoclasts.

Hu Y, Carraro-Lacroix LR, Wang A, Owen C, Bajenova E, Corey PN, Brumell JH, Voronov I.

J Cell Biochem. 2016 Feb;117(2):413-25. doi: 10.1002/jcb.25287.

PMID:
26212375
11.

Select microtubule inhibitors increase lysosome acidity and promote lysosomal disruption in acute myeloid leukemia (AML) cells.

Bernard D, Gebbia M, Prabha S, Gronda M, MacLean N, Wang X, Hurren R, Sukhai MA, Cho EE, Manolson MF, Datti A, Wrana J, Minden MD, Al-Awar R, Aman A, Nislow C, Giaever G, Schimmer AD.

Apoptosis. 2015 Jul;20(7):948-59. doi: 10.1007/s10495-015-1123-3.

PMID:
25832785
12.

Novel techniques in the development of osteoporosis drug therapy: the osteoclast ruffled-border vacuolar H(+)-ATPase as an emerging target.

Kartner N, Manolson MF.

Expert Opin Drug Discov. 2014 May;9(5):505-22. doi: 10.1517/17460441.2014.902155. Review.

PMID:
24749538
13.

The R740S mutation in the V-ATPase a3 subunit results in osteoclast apoptosis and defective early-stage autophagy.

Ochotny N, Voronov I, Owen C, Aubin JE, Manolson MF.

J Cell Biochem. 2013 Dec;114(12):2823-33. doi: 10.1002/jcb.24630.

PMID:
23908015
14.

VMA21 deficiency prevents vacuolar ATPase assembly and causes autophagic vacuolar myopathy.

Ramachandran N, Munteanu I, Wang P, Ruggieri A, Rilstone JJ, Israelian N, Naranian T, Paroutis P, Guo R, Ren ZP, Nishino I, Chabrol B, Pellissier JF, Minetti C, Udd B, Fardeau M, Tailor CS, Mahuran DJ, Kissel JT, Kalimo H, Levy N, Manolson MF, Ackerley CA, Minassian BA.

Acta Neuropathol. 2013 Mar;125(3):439-57. doi: 10.1007/s00401-012-1073-6. Epub 2013 Jan 12.

PMID:
23315026
15.

Topology, glycosylation and conformational changes in the membrane domain of the vacuolar H+-ATPase a subunit.

Kartner N, Yao Y, Bhargava A, Manolson MF.

J Cell Biochem. 2013 Jul;114(7):1474-87. doi: 10.1002/jcb.24489.

PMID:
23296946
16.

Luteolin inhibition of V-ATPase a3-d2 interaction decreases osteoclast resorptive activity.

Crasto GJ, Kartner N, Yao Y, Li K, Bullock L, Datti A, Manolson MF.

J Cell Biochem. 2013 Apr;114(4):929-41. doi: 10.1002/jcb.24434.

PMID:
23129004
17.

The R740S mutation in the V-ATPase a3 subunit increases lysosomal pH, impairs NFATc1 translocation, and decreases in vitro osteoclastogenesis.

Voronov I, Ochotny N, Jaumouillé V, Owen C, Manolson MF, Aubin JE.

J Bone Miner Res. 2013 Jan;28(1):108-18. doi: 10.1002/jbmr.1727.

18.

Osteopetrosis mutation R444L causes endoplasmic reticulum retention and misprocessing of vacuolar H+-ATPase a3 subunit.

Bhargava A, Voronov I, Wang Y, Glogauer M, Kartner N, Manolson MF.

J Biol Chem. 2012 Aug 3;287(32):26829-39. doi: 10.1074/jbc.M112.345702. Epub 2012 Jun 8.

19.

V-ATPase subunit interactions: the long road to therapeutic targeting.

Kartner N, Manolson MF.

Curr Protein Pept Sci. 2012 Mar;13(2):164-79. Review.

PMID:
22044155
20.

Mouse FLRT2 interacts with the extracellular and intracellular regions of FGFR2.

Wei K, Xu Y, Tse H, Manolson MF, Gong SG.

J Dent Res. 2011 Oct;90(10):1234-9. doi: 10.1177/0022034511415272. Epub 2011 Jul 15.

PMID:
21765038

Supplemental Content

Loading ...
Support Center